0.4534
Biodesix Inc stock is traded at $0.4534, with a volume of 1.87M.
It is up +6.98% in the last 24 hours and up +25.94% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.4238
Open:
$0.4238
24h Volume:
1.87M
Relative Volume:
0.24
Market Cap:
$66.48M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-0.6975
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
+14.41%
1M Performance:
+25.94%
6M Performance:
-48.59%
1Y Performance:
-74.24%
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BDSX
Biodesix Inc
|
0.4534 | 62.32M | 49.09M | -52.15M | -45.93M | -0.65 |
![]()
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
Jul-26-24 | Initiated | Craig Hallum | Buy |
May-13-24 | Initiated | TD Cowen | Buy |
May-03-24 | Initiated | Lake Street | Buy |
Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-23-20 | Initiated | BTIG Research | Buy |
Nov-23-20 | Initiated | Canaccord Genuity | Buy |
Nov-23-20 | Initiated | Morgan Stanley | Overweight |
Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Fibonacci Support Holding Strong in Biodesix Inc.July 2025 Institutional & Weekly Sector Rotation Insights - classian.co.kr
Will Biodesix Inc. Reverse From Oversold ConditionsQuarterly Performance Summary & AI Based Buy and Sell Signals - beatles.ru
Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewswire
Biodesix Designated Thermo Fisher Center of Excellence for NGS-Based Diagnostics. - AInvest
Biodesix Validates Thermo Fisher's Oncomine Dx Express Test for Solid Tumors on Genexus Dx Integrated Sequencer. - AInvest
Major Diagnostic Partnership: Biodesix Joins Elite Group as Thermo Fisher Center of Excellence for Cancer Testing - Stock Titan
Wyckoff Accumulation Phase Possible in Biodesix Inc.July 2025 Review & Long-Term Growth Stock Strategies - newsimpact.co.kr
Options Data Show Bullish Bias in Biodesix Inc.July 2025 Breakouts & AI Enhanced Market Trend Forecasts - newsyoung.net
Biodesix, Inc. Reports Strong Q2 2025 Growth - MSN
What makes Biodesix Inc. stock price move sharplyBond Market & Short-Term Trading Alerts - thegnnews.com
Biodesix Inc. Stocks Attracting Dip BuyersJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - newsyoung.net
Is This the Dip to Buy in Biodesix Inc.Wall Street Watch & AI Driven Price Predictions - newsimpact.co.kr
What MACD and RSI say about Biodesix Inc.Portfolio Risk Summary & Weekly Breakout Watchlists - Newser
Biodesix (NASDAQ:BDSX) Releases Earnings Results - MarketBeat
Combining machine learning predictions for Biodesix Inc.2025 Technical Patterns & Risk Managed Investment Signals - Newser
Price momentum metrics for Biodesix Inc. explainedJuly 2025 Decliners & Smart Money Movement Alerts - Newser
Combining price and volume data for Biodesix Inc.Quarterly Profit Review & Community Verified Watchlist Alerts - Newser
AI Indicators Detect Buy Opportunity in Biodesix Inc.CEO Change & Fast Entry and Exit Trade Plans - kangso.co.kr
Can Biodesix Inc. Outperform Peers After Recent PullbackExit Point & Proven Capital Preservation Methods - thegnnews.com
Will Biodesix Inc. Benefit From Sector TailwindsTrade Performance Summary & Low Volatility Stock Recommendations - newsimpact.co.kr
Blair William & Co. IL Has $78,000 Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Is a relief rally coming for Biodesix Inc. holders2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Will Biodesix Inc. bounce back from current supportFed Meeting & Risk Managed Investment Strategies - Newser
Earnings visualization tools for Biodesix Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Biodesix at Canaccord Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com Canada
Is Biodesix Inc. a strong growth stockUndervalued High Return Candidates - kangso.co.kr
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript - Insider Monkey
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛
Should I add Biodesix Inc. stock to my portfolioMulti-Year Breakout Candidates - thegnnews.com
Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance
Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest
Biodesix reports strong Q2 revenue growth - BizWest
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest
Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest
Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks
Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize
Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener
Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa
Biodesix earnings missed, revenue topped estimates - Investing.com
Biodesix Announces Second Quarter 2025 Results and Highlights - The Manila Times
Biodesix Soars 14.1% on Conference Presentation - AInvest
Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biodesix Inc Stock (BDSX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
O'Kane Kieran | Chief Commercial Officer |
Aug 13 '25 |
Sale |
0.42 |
476 |
198 |
140,065 |
Pestano Gary Anthony | Chief Development Officer |
Aug 13 '25 |
Sale |
0.42 |
442 |
184 |
157,878 |
Vazquez Chris | Chief Accounting Officer |
Aug 13 '25 |
Sale |
0.42 |
228 |
95 |
18,375 |
SCHULER JACK W | Director |
May 16 '25 |
Buy |
0.27 |
4,000,000 |
1,070,000 |
20,194,935 |
SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
Vazquez Chris | Chief Accounting Officer |
May 12 '25 |
Sale |
0.36 |
112 |
40 |
18,113 |
Vazquez Chris | Chief Accounting Officer |
May 13 '25 |
Sale |
0.35 |
112 |
40 |
18,001 |
Pestano Gary Anthony | Chief Development Officer |
May 12 '25 |
Sale |
0.36 |
223 |
80 |
157,163 |
Pestano Gary Anthony | Chief Development Officer |
May 13 '25 |
Sale |
0.35 |
222 |
78 |
156,941 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):